Therapeutic Topic Use of Chamomilla Recutita in Phlebitis Due to Peripheral Intravenous Therapy
The hypothesis adopted was that patients with phlebitis due to peripheral intravenous
infusion in anti-neoplasm chemotherapy, treated with a compress of Chamomilla recutita
infusion for 20 minutes three times per day, would present a shorter phlebitis regression
time in comparison with patients treated with a lukewarm water compress.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
phlebitis regression time
medium of 7 days
Yes
Paula ED Reis, RN, PhD
Principal Investigator
University of Sao Paulo
Brazil: Ethics Committee
USPRecutita-01
NCT00989599
September 2004
September 2008
Name | Location |
---|